Drug Type Chemical drugs, Peptides |
Synonyms OLP 210, OLP210 |
Target |
Action modulators |
Mechanism GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Phase 1 | China | 05 Aug 2025 | |
| Endocrine System Diseases | Preclinical | China | 29 Jan 2024 |





